Quality custom vaccines from Cambridge Technologies are formulated and produced at our USDA-licensed 37,000-square-foot production facility, featuring a state-of-the-art fermentation suite.  No matter the size of the order, Cambridge Technologies can meet your needs. We have the ability to customize products to each customer's individual needs, including: the potential for antigen concentration, multiple adjuvant choices, a range of label color options, and the option of SoliDose^® implants in bovine products.

Features and options of our production facility include:

• Batch size capacity of 1,500 liters
• 600L and 1,600L fermenters for large-scale production
• Dedicated areas for virus and bacterin production
• ISO Class 5 fill suites
• Production methods that optimize antigen expression
• Flexibility in formulation: dose size, bottle size,
  preservative-free product, adjuvant-free concentrated antigen
• Microfiltration and ultrafiltration techniques